Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ESMO open

Showing results (31-40 of 2,232) with videos related to

Pageof 224
Sort By:
ESMO Open|December 25, 2021
Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancerL-K Chang, Y-W Kuo, S-G Wu, et al.
ESMO Open|December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspectiveC Sessa, J Cortes, P Conte, et al.
ESMO Open|February 5, 2022
Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement ProcessI Wolf, B Waissengrin, A Zer, et al.
ESMO Open|February 14, 2022
Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trialsC W Szeto, R Kurzrock, S Kato, et al.
ESMO Open|April 26, 2022
In the literature: April 2022D Ciardiello, D Roda, V Gambardella, et al.
ESMO Open|October 15, 2021
Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancerQ Gou, C Z Zhang, Z H Sun, et al.
ESMO Open|October 1, 2021
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatmentM Peeters, L Verbruggen, L Teuwen, et al.
ESMO Open|October 1, 2021
Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic reviewM Garutti, M Lambertini, F Puglisi
ESMO Open|October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONOD Rossini, A Boccaccino, A Sbrana, et al.
ESMO Open|October 24, 2021
Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM databaseA Bassompierre, S Dalac, B Dreno, et al.
Pageof 224

Showing results (31-40 of 2,232) with videos related to

Sort By:
Pageof 224
ESMO Open|December 25, 2021
Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancerL-K Chang, Y-W Kuo, S-G Wu, et al.
ESMO Open|December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspectiveC Sessa, J Cortes, P Conte, et al.
ESMO Open|February 5, 2022
Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement ProcessI Wolf, B Waissengrin, A Zer, et al.
ESMO Open|February 14, 2022
Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trialsC W Szeto, R Kurzrock, S Kato, et al.
ESMO Open|April 26, 2022
In the literature: April 2022D Ciardiello, D Roda, V Gambardella, et al.
ESMO Open|October 15, 2021
Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancerQ Gou, C Z Zhang, Z H Sun, et al.
ESMO Open|October 1, 2021
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatmentM Peeters, L Verbruggen, L Teuwen, et al.
ESMO Open|October 1, 2021
Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic reviewM Garutti, M Lambertini, F Puglisi
ESMO Open|October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONOD Rossini, A Boccaccino, A Sbrana, et al.
ESMO Open|October 24, 2021
Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM databaseA Bassompierre, S Dalac, B Dreno, et al.
Pageof 224